Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Malignant Lymphoma

  Free Subscription

Articles published in Int J Cancer

Retrieve available abstracts of 27 articles:
HTML format

Single Articles

    June 2022
  1. YARMOLINSKY J, Amos CI, Hung RJ, Moreno V, et al
    Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma risk.
    Int J Cancer. 2022 Jun 23. doi: 10.1002/ijc.34180.
    PubMed     Abstract available

  2. MAFRA A, Laversanne M, Gospodarowicz M, Klinger P, et al
    Global patterns of non-Hodgkin lymphoma in 2020.
    Int J Cancer. 2022 Jun 13. doi: 10.1002/ijc.34163.
    PubMed     Abstract available

    April 2022
  3. ABRAHAO R, Cooley JJP, Maguire FB, Parikh-Patel A, et al
    Stage at diagnosis and survival among adolescents and young adults with lymphomas following the Affordable Care Act implementation in California.
    Int J Cancer. 2022;150:1113-1122.
    PubMed     Abstract available

    January 2022
  4. SINGH D, Vaccarella S, Gini A, Silva NP, et al
    Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040.
    Int J Cancer. 2022 Jan 26. doi: 10.1002/ijc.33948.
    PubMed     Abstract available

    December 2021
  5. YOSHIDA-SAKAI N, Watanabe T, Yamamoto Y, Ureshino H, et al
    Adult T-cell leukemia-lymphoma acquires resistance to DNA demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism.
    Int J Cancer. 2021 Dec 16. doi: 10.1002/ijc.33901.
    PubMed     Abstract available

  6. JI J, Liu Z, Kuang P, Dong T, et al
    A new conditioning regimen with chidamide, cladribine, gemcitabine and busulfan significantly improve the outcome of high-risk or relapsed/refractory non-Hodgkin's lymphomas.
    Int J Cancer. 2021;149:2075-2082.
    PubMed     Abstract available

  7. FOUNTZILAS C, Adjei A, Opyrchal M, Evans R, et al
    A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine-based chemotherapy in patients with advanced solid tumors.
    Int J Cancer. 2021;149:2063-2074.
    PubMed     Abstract available

    October 2021
  8. WU J, Song Y, Chen X, Lin T, et al
    Camrelizumab for relapsed or refractory classical Hodgkin lymphoma: extended follow-up of the multicenter, single-arm, phase 2 study.
    Int J Cancer. 2021 Oct 21. doi: 10.1002/ijc.33852.
    PubMed     Abstract available

  9. MPUNGA T, Clifford GM, Morgan EA, Milner DA Jr, et al
    Epstein-Barr virus prevalence among subtypes of malignant lymphoma in Rwanda, 2012-2018.
    Int J Cancer. 2021 Oct 9. doi: 10.1002/ijc.33840.
    PubMed     Abstract available

    September 2021
  10. SHEN Z, Hu L, Yao M, He C, et al
    Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and EBER status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group.
    Int J Cancer. 2021 Sep 14. doi: 10.1002/ijc.33802.
    PubMed     Abstract available

    July 2021
  11. DE ROOS AJ, Schinasi LH, Miligi L, Cerhan JR, et al
    Occupational Insecticide Exposure and Risk of Non-Hodgkin Lymphoma: A Pooled Case-Control Study from the InterLymph Consortium.
    Int J Cancer. 2021 Jul 16. doi: 10.1002/ijc.33740.
    PubMed     Abstract available

    June 2021
  12. HERDA S, Heimann A, Obermayer B, Ciraolo E, et al
    Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challenges.
    Int J Cancer. 2021;148:3097-3110.
    PubMed     Abstract available

  13. JAQUET A, Boni SP, Boidy K, Tine J, et al
    Chronic viral hepatitis, HIV infection and Non-Hodgkin lymphomas in West Africa, a case-control study.
    Int J Cancer. 2021 Jun 14. doi: 10.1002/ijc.33709.
    PubMed     Abstract available

  14. PARKIN DM, Youlden DR, Chitsike I, Chokunonga E, et al
    Stage at diagnosis and survival by stage for the leading childhood cancers in three populations of sub-Saharan Africa.
    Int J Cancer. 2021;148:2685-2691.
    PubMed     Abstract available

    April 2021
  15. SHI Z, Wei J, Na R, Resurreccion WK, et al
    Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank.
    Int J Cancer. 2021;148:1658-1664.
    PubMed     Abstract available

  16. SOLIMAN RM, Elhaddad A, Oke J, Eweida W, et al
    Temporal trends in childhood cancer survival in Egypt, 2007 to 2017: A large retrospective study of 14 808 children with cancer from the Children's Cancer Hospital Egypt.
    Int J Cancer. 2021;148:1562-1574.
    PubMed     Abstract available

    March 2021
  17. GAUT D, Tang K, Sim MS, Duong T, et al
    Filgrastim associations with CAR T-cell therapy.
    Int J Cancer. 2021;148:1192-1196.
    PubMed     Abstract available

    February 2021
  18. LIEBOW M, Larson MC, Thompson CA, Nowakowski GS, et al
    Aspirin and other nonsteroidal anti-inflammatory drugs, statins, and risk of non-Hodgkin lymphoma.
    Int J Cancer. 2021 Feb 28. doi: 10.1002/ijc.33541.
    PubMed     Abstract available

    November 2020
  19. JIANG S, Qin Y, Jiang H, Liu B, et al
    Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroup.
    Int J Cancer. 2020;147:2611-2620.
    PubMed     Abstract available

    October 2020
  20. SABERI HOSNIJEH F, Casabonne D, Nieters A, Solans M, et al
    Association between anthropometry and lifestyle factors and risk of B cell lymphoma: an exposome wide analysis.
    Int J Cancer. 2020 Oct 31. doi: 10.1002/ijc.33369.
    PubMed     Abstract available

  21. ZHANG L, Wang Y, Li X, Li L, et al
    Radiotherapy vs sequential DDGP and radiotherapy in newly diagnosed early NK/T cell lymphoma: A randomized, controlled, open-label, multicenter study.
    Int J Cancer. 2020 Oct 9. doi: 10.1002/ijc.33329.
    PubMed     Abstract available

    August 2020
  22. KANE E, Painter D, Smith A, Lamb M, et al
    Risk of mature B-cell neoplasms and precursor conditions after joint replacement: A report from the Haematological Malignancy Research Network.
    Int J Cancer. 2020;147:702-708.
    PubMed     Abstract available

    July 2020
  23. ROIDER T, Wang X, Huttl K, Muller-Tidow C, et al
    The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
    Int J Cancer. 2020 Jul 7. doi: 10.1002/ijc.33202.
    PubMed     Abstract available

    June 2020
  24. KACHURI L, Beane Freeman LE, Spinelli JJ, Blair A, et al
    Insecticide use and risk of non-Hodgkin lymphoma subtypes: a subset meta-analysis of the North American Pooled Project.
    Int J Cancer. 2020 Jun 23. doi: 10.1002/ijc.33164.
    PubMed     Abstract available

  25. DEUBLER EL, Gapstur SM, Diver WR, Gaudet MM, et al
    Erythrocyte Levels of Cadmium and Lead and Risk of B-Cell Non-Hodgkin Lymphoma and Multiple Myeloma.
    Int J Cancer. 2020 Jun 7. doi: 10.1002/ijc.33136.
    PubMed     Abstract available

    April 2020
  26. LI M, Shen Y, Chen Y, Gao H, et al
    Characterization of hepatitis B virus infection and viral DNA integration in non-Hodgkin lymphoma.
    Int J Cancer. 2020 Apr 29. doi: 10.1002/ijc.33027.
    PubMed     Abstract available

    January 2020
  27. TRICKEY A, May MT, Gill MJ, Grabar S, et al
    Cause-specific mortality after diagnosis of cancer among HIV-positive patients: a collaborative analysis of cohort studies.
    Int J Cancer. 2020 Jan 31. doi: 10.1002/ijc.32895.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.